Home / Healthcare / Urology Lasers Market

Urology Lasers Market Size, Share & Industry Analysis, By Type (Holmium Laser System, Diode Laser Systems, Thulium Laser System, Others), By Applications (Urinary Calculi, Benign Prostatic Hyperplasia, Tumors, Others), By End-User (Hospitals, Urology Clinics, Ambulatory Surgical Centres, Others) and Regional Forecast, 2024-2032

Report Format: PDF | Published Date: Ongoing | Report ID: FBI103124 | Status : Upcoming

The laser is preferred in urology due to the ability of the it to ablate tissues with minimal internal bleeding. Moreover, the lasers being minimally invasive in nature, it has concentrated most of the interest in urological practices. Nowadays, lasers have been adopted widely in urology for treatment and to deal with many conditions such as urinary calculi, stricture, benign prostatic hyperplasia, and tumours. The urology lasers market is growing due to factors such as growing geriatric population, increasing prevalence of chronic kidney diseases.


Increase in the prevalence of kidney diseases and the growing geriatric population are the major factors driving the growth of the market. The elderly population is more prone to develop various kidney problems and conditions. According to the National Institute of Health 2017, benign prostatic hyperplasia (BPH) is one of the most general diseases affecting kidneys in elderly people and the most common source of lower urinary tract symptoms (LUTS). The prevalence of BPH is more among elderly population more than 40 years of age. Moreover, according to the journal of urology 2018, urolithiasis is expected to affect 12% of the global population by 2025. The overall growth of the market can be accredited to the increasing geriatric population, technological advancements, and minimally invasiveness nature of the lasers. Also rising initiatives by public and private organizations to improve healthcare across the globe is fuelling the growth of this market.


However, high cost of the lasers and stringent regulatory requirements for the medical approval of lasers are also impeding the growth of the market.



Market Segmentation:


Globally, the urology lasers market can be segmented on the basis of type, applications, end-users, and region. Based on the type, the market can be segmented into holmium laser system, diode laser systems, thulium laser system, and others. Based on the application, the market can be segmented into urinary calculi, benign prostatic hyperplasia, tumors, and others. Based on the end-users the market can be segmented into hospitals, urology clinics, ambulatory surgical centres, and others.


Geographically, the urology lasers market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa.


Key Players Covered:


Some of the major companies that are present in the urology lasers market are Olympus Corporation, Boston Scientific Corporation, Richard Wolf GmbH, Cook Group, Medtronic, biolitec AG, Lumenis, Asclepion Laser Technologies GmbH and other prominent players.


Key Insights:



  • Prevalence of Kidney Diseases by Key Countries/Region

  • Technological Advancements by Key Countries/Region,

  • Introduction of New Products/Approvals (By Major Players)

  • Key Industry Developments Mergers, Acquisitions, and Collaborations


Regional Analysis:


Geographically, the urology lasers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North American region is likely to have the lion’s share of the market and is also projected to follow the same impulsion during the forecast period. The growth of the market in this region can be recognized by the presence of skilled professionals, sophisticated healthcare groundwork along and the presence of baby boomer population. Moreover, an increase in the prevalence of chronic kidney diseases and availability & adoption of technologically advanced product is also driving the market in this region. Europe is projected to be the second most productive market throughout the forecast period. The factors such as the implementation of innovative medical technologies, increase in the prevalence of kidney diseases, rise in geriatric population, growing awareness regarding physical and health-related issues in this region are anticipated to boost the growth of the urology lasers market in this region. However, Asia-Pacific holds great potential for the growth of the market. The high potential for the growth of the market can be accredited to the increase in the aged population, growing incidence and prevalence of kidney disorders. The market in Latin America and the Middle East and Africa are expected to grow reasonably in the forecast period



Segmentation


























 ATTRIBUTE


  DETAILAS

By Type




  • Holmium Laser System

  • Diode Laser Systems

  • Thulium Laser System

  • Others



By Applications




  • Urinary Calculi

  • Benign Prostatic Hyperplasia

  • Tumors

  • Others



By End-User




  • Hospitals

  • Urology Clinics

  • Ambulatory Surgical Centres

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Urology Lasers Market Industry Developments



  • In October 2019, Cook Group and Quanta System entered into an agreement in which Cook will distribute in some territories a comprehensive offering of Quanta’s holmium and thulium laser systems, laser fibers and accessories. This collaboration will ensure that physicians have access to the latest laser technology to treat their patients, along with Cook’s current comprehensive line of disposable products.

  • In March 2018, Boston Scientific Corporation acquired a privately-held company NxThera, based in Maple Grove, Minnesota. NxThera developed and commercialized, in the United States (U.S.) and Europe, the Rezūm system which is a minimally invasive therapy in a growing category of treatment options for men with symptoms arising from of benign prostatic hyperplasia (BPH).

  • Global
  • 2023
  • 2019-2022
  • PRICE
  • $ 4850
    $ 5850
    $ 6850
    Pre Book

Healthcare Clients